![Thomas Ulmer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Ulmer
Finansdirektör/CFO på
PYC THERAPEUTICS LIMITED
Profil
Thomas Ulmer is currently Non-Executive Director at Aravax Pty Ltd. since 2020 and Chief Financial Officer at PYC Therapeutics Ltd. starting in 2026.
Formerly, Mr. Ulmer was Co-Managing Director at Immatics Biotechnologies GmbH from 2018 to 2020, Head-Planning, Forecasting & Resource Allocation at Merck KGaA from 2012 to 2016, Chief Financial Officer at Immatics NV, and Chief Financial Officer at Cell Therapies Pty Ltd. Education includes an MBA from the University of Giessen.
Aktiva positioner av Thomas Ulmer
| Företag | Position | Start |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Finansdirektör/CFO | 2026-07-07 |
Aravax Pty Ltd.
 Aravax Pty Ltd. BiotechnologyHealth Technology Develops treatments for peanut allergies | Direktör/Styrelseledamot | 2020-11-01 |
Tidigare kända positioner av Thomas Ulmer
| Företag | Position | Slut |
|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Verkställande Direktör | 2020-02-12 |
| MERCK KGAA | Företagsledare/Principal | 2016-07-01 |
Cell Therapies Pty Ltd. | Finansdirektör/CFO | - |
| IMMATICS N.V. | Finansdirektör/CFO | - |
Thomas Ulmers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
61
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
University of Giessen
 University of Giessen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Therapies Pty Ltd. | |
Aravax Pty Ltd.
Aravax Pty Ltd. BiotechnologyHealth Technology Develops treatments for peanut allergies | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
